Trial intelligence / Profile preview

Morphine Sparing Effect of Intermittent Versus Continuous Intravenous Infusion of Nefopam After Total Knee Arthroplasty

TCTR202103160010Phase 4Recruiting

Sponsor
N/A
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nefopam in postoperative pain, sponsored by N/A. Started Mar 2021; status: recruiting.

02

Drugs

nefopam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on TCTR202103160010.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR202103160010.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call